Nontuberculous mycobacteria

被引:49
作者
Holland, SM [1 ]
机构
[1] NIAID, Host Def Lab, Clin Pathophysiol Sect, Immunopathogenesis Unit,NIH, Bethesda, MD 20892 USA
关键词
interferon gamma; mycobacteria; immunodeficiency; receptors;
D O I
10.1097/00000441-200101000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The nontuberculous mycobacteria are for the most part ubiquitous environmental organisms that only rarely cause disease in humans. Therefore, the normal host defense against these organisms must be quite robust, as exposure is universal and disease is rare. The organisms that are most commonly encountered in clinical practice, Mycobacterium avium, M intracellulare, M kansasii, M fortuitum, M abscessus, and M chelonae, are frequently found in water sources and soil.(1) These organisms share significant structural and biochemical similarities with their more pathogenic relative, M tuberculosis (MTB). Because they are of significantly lower pathogenicity than MTB, patients with abnormal susceptibility to these infections should include those with defects that may be identifiable. Study of these patients should lead to determination of the mechanisms underlying resistance to these organisms, which in turn are likely to be highly informative regarding host defense against these infections and their more virulent relative MTB. Furthermore, recognition of host factors that permit infection with nontuberculous mycobacteria in otherwise normal hosts will identify pathways that can be targeted for therapeutic intervention. Thus, the search for genetic and acquired susceptibility to nontuberculous mycobacteria is also a search for susceptibility factors for MTB as well as an opportunity to recognize endogenous pathways that can be exploited therapeutically.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 53 条
  • [1] AHN CH, 1986, AM REV RESPIR DIS, V134, P438
  • [2] Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection
    Altare, F
    Lammas, D
    Revy, P
    Jouanguy, E
    Döffinger, R
    Lamhamedi, S
    Drysdale, P
    Scheel-Toellner, D
    Girdlestone, J
    Darbyshire, P
    Wadhwa, M
    Dockrell, H
    Salmon, M
    Fischer, A
    Durandy, A
    Casanova, JL
    Kumararatne, DS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (12) : 2035 - 2040
  • [3] Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
    Altare, F
    Durandy, A
    Lammas, D
    Emile, JF
    Lamhamedi, S
    Le Deist, F
    Drysdale, P
    Jouanguy, E
    Döffinger, R
    Bernaudin, F
    Jeppsson, O
    Gollob, JA
    Meinl, E
    Segal, AW
    Fischer, A
    Kumararatne, D
    Casanova, JL
    [J]. SCIENCE, 1998, 280 (5368) : 1432 - 1435
  • [4] Variations in the Nrampi gene and susceptibility to tuberculosis in West Africans
    Bellamy, R
    Ruwende, C
    Corrah, T
    McAdam, KPWJ
    Whittle, HC
    Hill, AVS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (10) : 640 - 644
  • [5] Cellular responses to interferon-gamma
    Boehm, U
    Klamp, T
    Groot, M
    Howard, JC
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 749 - 795
  • [6] AEROSOLIZED INTERFERON-GAMMA FOR MYCOBACTERIUM AVIUM-COMPLEX LUNG-DISEASE
    CHATTE, G
    PANTEIX, G
    PERRINFAYOLLE, M
    PACHECO, Y
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (03) : 1094 - 1096
  • [7] Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol
    Condos, R
    Rom, WN
    Schluger, NW
    [J]. LANCET, 1997, 349 (9064) : 1513 - 1515
  • [8] STATs and gene regulation
    Darnell, JE
    [J]. SCIENCE, 1997, 277 (5332) : 1630 - 1635
  • [9] Doherty TM, 1997, J IMMUNOL, V158, P4822
  • [10] Interferon-γ and interleukin-12 pathway defects and human disease
    Dorman, SE
    Holland, SM
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2000, 11 (04) : 321 - 333